Randox TxBCardio-for urinary evaluation of aspirin response

The Randox TxBCardio assay offers laboratories an automated immunoturbidimetric test which allows aspirin therapy response to be assessed on clinical chemistry analysers and removes the need for any additional, dedicated equipment.
Randox TxBCardio delivers a highly accurate testing method by specifically measuring the 11dhTxB₂ metabolite.  Additional beneficial features of the Randox TxBCardio assay include the fact it is designed for use with urine samples, facilitating easier sample collection and storage; it is in a liquid ready-to-use format for optimum convenience; and it delivers an extensive assay range of 400-6000 pg/ml. Furthermore, Randox TxBCardio is suitable for use on a wide range of clinical chemistry analysers via a variety of instrument specific applications.

Supplier: Randox Laboratories Ltd.
Website:

Mail the supplier